Lb Pharmaceuticals LBRX
NASDAQ LBRX
$44.71 -0.23 (-0.51%)
At close: Nov 11, 2026 · 4:00 PM EST

Lb Pharmaceuticals (LBRX) Depreciation & Amortization (CF) (2025 - 2026)

Updated

Lb Pharmaceuticals (LBRX) recorded Depreciation & Amortization (CF) of $97,000 in Q2 2026, up 27.6% from $76,000 a year earlier and up 18.3% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

On a TTM basis, Lb Pharmaceuticals' Depreciation & Amortization (CF) came in at $336,000 as of Jun 30, 2026; for FY2025, it came in at $321,000, up 252.7% from FY2024.

  • Across earlier years, Depreciation & Amortization (CF) came in at $91,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Lb Pharmaceuticals 1.45 Bn 410.04 Mn - 124,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 124,000.00
Jun 30, 2026 97,000.00
Mar 31, 2026 82,000.00
Sep 30, 2025 81,000.00
Jun 30, 2025 76,000.00
Mar 31, 2025 79,000.00
API Access

Lb Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LBRX&period=max&api_key=YOUR_API_KEY